Emergence Therapeutics Raises €87 Million Series A Financing To Advance Nectin-4 Adc
Dec 07, 2021•over 3 years ago
Amount Raised
€87 Million
Round Type
series a
Description
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech